168 related articles for article (PubMed ID: 35807172)
21. SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database.
Ado Moumouni AN; Robin P; Hillaire-Buys D; Faillie JL
Fundam Clin Pharmacol; 2018 Apr; 32(2):216-226. PubMed ID: 29144574
[TBL] [Abstract][Full Text] [Related]
22. Sleep-related eating disorder versus sleepwalking: a controlled study.
Brion A; Flamand M; Oudiette D; Voillery D; Golmard JL; Arnulf I
Sleep Med; 2012 Sep; 13(8):1094-101. PubMed ID: 22841035
[TBL] [Abstract][Full Text] [Related]
23. Two Cases of Sleep-Related Eating Disorder Responding Promptly to Low-Dose Sertraline Therapy.
Varghese R; Rey de Castro J; Liendo C; Schenck CH
J Clin Sleep Med; 2018 Oct; 14(10):1805-1808. PubMed ID: 30353815
[TBL] [Abstract][Full Text] [Related]
24. Zolpidem-induced sleep-related eating disorder.
Yun CH; Ji KH
J Neurol Sci; 2010 Jan; 288(1-2):200-1. PubMed ID: 19822330
[TBL] [Abstract][Full Text] [Related]
25. Sleep-related eating disorder: a descriptive study in Chilean patients.
Santin J; Mery V; Elso MJ; Retamal E; Torres C; Ivelic J; Godoy J
Sleep Med; 2014 Feb; 15(2):163-7. PubMed ID: 24424097
[TBL] [Abstract][Full Text] [Related]
26. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
[TBL] [Abstract][Full Text] [Related]
27. Zolpidem Induced Sleep-related Eating and Complex Behaviors in a Patient with Obstructive Sleep Apnea and Restless Legs Syndrome.
Park YM; Shin HW
Clin Psychopharmacol Neurosci; 2016 Aug; 14(3):299-301. PubMed ID: 27489385
[TBL] [Abstract][Full Text] [Related]
28. Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Mazhar F; Pozzi M; Gentili M; Scatigna M; Clementi E; Radice S; Carnovale C
CNS Drugs; 2019 Jun; 33(6):581-592. PubMed ID: 30977109
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment with clonazepam and pramipexole of a patient with sleep-related eating disorder associated with restless legs syndrome: a case report.
Kobayashi N; Yoshimura R; Takano M
Case Rep Med; 2012; 2012():893681. PubMed ID: 22481958
[TBL] [Abstract][Full Text] [Related]
30. [Sleep related eating disorder].
Inoue Y; Komada Y
Seishin Shinkeigaku Zasshi; 2010; 112(9):912-20. PubMed ID: 21077298
[TBL] [Abstract][Full Text] [Related]
31. Safety of antipsychotic drugs: A systematic review of disproportionality analysis studies.
Cepaityte D; Siafis S; Papazisis G
Behav Brain Res; 2021 Apr; 404():113168. PubMed ID: 33581145
[TBL] [Abstract][Full Text] [Related]
32. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
33. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database.
Gastaldon C; Schoretsanitis G; Arzenton E; Raschi E; Papola D; Ostuzzi G; Moretti U; Seifritz E; Kane JM; Trifirò G; Barbui C
Drug Saf; 2022 Dec; 45(12):1539-1549. PubMed ID: 36400895
[TBL] [Abstract][Full Text] [Related]
34. Defining the borders between Sleep-Related Eating Disorder and Night Eating Syndrome.
Vinai P; Ferri R; Ferini-Strambi L; Cardetti S; Anelli M; Vallauri P; Ferrato N; Zucconi M; Carpegna G; Manconi M
Sleep Med; 2012 Jun; 13(6):686-90. PubMed ID: 22456111
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety Database.
Merino D; Gérard AO; Van Obberghen EK; Ben Othman N; Ettore E; Giordana B; Viard D; Rocher F; Destere A; Benoit M; Drici MD
Front Pharmacol; 2022; 13():909412. PubMed ID: 35668936
[TBL] [Abstract][Full Text] [Related]
36. A review of nighttime eating disorders.
Howell MJ; Schenck CH; Crow SJ
Sleep Med Rev; 2009 Feb; 13(1):23-34. PubMed ID: 18819825
[TBL] [Abstract][Full Text] [Related]
37. SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports.
Palapra H; Viswam SK; Kalaiselvan V; Undela K
Int J Clin Pharm; 2022 Dec; 44(6):1425-1433. PubMed ID: 36224513
[TBL] [Abstract][Full Text] [Related]
38. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
[TBL] [Abstract][Full Text] [Related]
39. Calcitonin gene-related peptide-targeting drugs and Raynaud's phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database.
Gérard AO; Merino D; Van Obberghen EK; Rocher F; Destere A; Lantéri-Minet M; Drici MD
J Headache Pain; 2022 May; 23(1):53. PubMed ID: 35505285
[TBL] [Abstract][Full Text] [Related]
40. Active-comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors.
Alkabbani W; Gamble JM
Br J Clin Pharmacol; 2023 Feb; 89(2):431-439. PubMed ID: 34964156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
